The Securities and Exchange Commission fanned the flames of controversy last week when it altered the effective date of stock option expensing to give the vast majority of public companies another six months to comply.
Reactions ranged from shock and anger on the part of the investor community to relief and rejoicing on the part of expensing critics, who have hinted they’ll take the six-month extension to continue pitching Congress for legislative intervention to overturn the rule.
